Tauriga Sciences, Inc. (TAUG) SEC Filing 8-K Material Event for the period ending Friday, September 13, 2019

Tauriga Sciences, Inc.

CIK: 1142790 Ticker: TAUG

View differences made from one to another to evaluate Tauriga Sciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Tauriga Sciences, Inc..


Assess how Tauriga Sciences, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Tauriga Sciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: TAUG
CIK: 1142790
Form Type: 8-K Corporate News
Accession Number: 0001493152-19-015189
Submitted to the SEC: Mon Oct 07 2019 9:47:08 PM EST
Accepted by the SEC: Tue Oct 08 2019
Period: Friday, September 13, 2019
Industry: Medicinal Chemicals And Botanical Products
  1. Bylaw Change
  2. Financial Exhibit
  3. New Agreement
  4. New Financial Obligation
  5. Regulated Disclosure
  6. Security Holders Change
  7. Unregistered Sales

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: